🔎 Trials Near Me

Domov › Akutna mieločna levkemija › Georgia › Atlanta

Klinične študije za Akutna mieločna levkemija v Atlanta, GA

31 študij za Akutna mieločna levkemija išče udeležence na lokacijah v Atlanta in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Vključevanje udeležencevFaza 1
  • Children'S Healthcare Of Atlanta - Arthur M. Blank Hospital /ID# 275740, Atlanta
6 Months – 17 Years · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07306832

Ivosidenib as Post-HSCT Maintenance for AML

Vključevanje udeležencevFaza 2
  • Emory University Hospital, Atlanta
Starost 18–75 · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06707493

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Vključevanje udeležencevFaza 1
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Do 21 let · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07012044

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Vključevanje udeležencevFaza 2/3
  • Winship Cancer Institute of Emory University /ID# 279006, Atlanta
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07581002

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • Atlanta VA Medical Center, Decatur · 6 mi stran
Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Vključevanje udeležencevOpazovalna študija
  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Starost 0–38 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06131801

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Vključevanje udeležencevFaza 1
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06484062

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Vključevanje udeležencevFaza 1
  • Emory University, Atlanta
Starost 12–78 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT03802695

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Vključevanje udeležencevFaza 3
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
6 Months – 21 Years · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Vključevanje udeležencevFaza 1/2
  • Emory Winship Cancer Institute, Atlanta
30 Days · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT04065399

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Vključevanje udeležencevFaza 2
  • Winship Cancer Institute - Emory University, Atlanta
Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT04996875

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Vključevanje udeležencevFaza 3
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Starost 1–25 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07022678

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

Vključevanje udeležencevFaza 3
  • US-Atlanta GA-EMORY, Atlanta
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06652438

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

Vključevanje udeležencevFaza 3
  • US-Atlanta GA-EMORY, Atlanta
Starost 18 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT07223814

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Vključevanje udeležencevFaza 1/2
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Do 22 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Vključevanje udeležencevFaza 3
  • Children's Healthcare of Atlanta, Atlanta
29 Days – 21 Years · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Vključevanje udeležencevFaza 1
  • Emory Healthcare - The Emory Clinic, Atlanta
Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT06001788

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Vključevanje udeležencevFaza 1
  • Children's Healthcare of Atlanta, Atlanta
Starost 1–30 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06177067

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
  • Northside Hospital, Atlanta
Starost 18–75 · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT07020533

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Vključevanje udeležencevFaza 3
  • Emory University - Winship Cancer Institute (WCI), Atlanta
Starost 18–75 · Vsi spoli · Posodobljeno 17. jul. 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Vključevanje udeležencevOpazovalna študija
  • Children's Healthcare of Atlanta, Atlanta
  • Northside Hospital, Atlanta
Vse starosti · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Vključevanje udeležencevFaza 1/2
  • Emory Winship Cancer Institute, Atlanta
Starost 18 in več · Vsi spoli · Posodobljeno 24. jun. 2026 · NCT04068597

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Vključevanje udeležencevFaza 1
  • Winship Cancer Institute / Emory University, Atlanta
Starost 18 in več · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT05768932

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Vključevanje udeležencevFaza 2/3
  • University of Emory - Winship Cancer Institute, Atlanta
Starost 18 in več · Vsi spoli · Posodobljeno 30. apr. 2026 · NCT04256317

Pilot Imaging Study of Leukemia

Vključevanje udeležencevFaza 1
  • Emory University, Atlanta
Starost 4–80 · Vsi spoli · Posodobljeno 23. apr. 2026 · NCT03633955

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Vključevanje udeležencevFaza 1
  • Emory Healthcare - The Emory Clinic, Atlanta
Starost 18 in več · Vsi spoli · Posodobljeno 13. mar. 2026 · NCT05735184

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
  • Northside Hospital, Atlanta
Starost 18–75 · Vsi spoli · Posodobljeno 10. mar. 2026 · NCT06059391

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Vključevanje udeležencevFaza 1
  • Emory University Hospital, Atlanta
Starost 18 in več · Vsi spoli · Posodobljeno 16. jan. 2026 · NCT05143996

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

Vključevanje udeležencevFaza 1
  • Emory University - WINSHIP Cancer Center, Atlanta
  • Emory University, Children's Healthcare of Atlanta, Atlanta
Starost 12 in več · Vsi spoli · Posodobljeno 8. jan. 2026 · NCT04872478

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

Vključevanje udeležencevFaza 1
  • Blood and Marrow Transplant Group of Georgia, Atlanta
Starost 18 in več · Vsi spoli · Posodobljeno 31. okt. 2025 · NCT06549790

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • Emory University, Atlanta
Starost 18–120 · Vsi spoli · Posodobljeno 25. jul. 2025 · NCT05237258

Študije za Akutna mieločna levkemija v drugih mestih

Druge študije v Atlanta

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.